These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Expression of wild type and mutant ELOVL4 in cell culture: subcellular localization and cell viability. Karan G, Yang Z, Zhang K. Mol Vis; 2004 Mar 31; 10():248-53. PubMed ID: 15073583 [Abstract] [Full Text] [Related]
3. Atrophic macular degeneration mutations in ELOVL4 result in the intracellular misrouting of the protein. Ambasudhan R, Wang X, Jablonski MM, Thompson DA, Lagali PS, Wong PW, Sieving PA, Ayyagari R. Genomics; 2004 Apr 31; 83(4):615-25. PubMed ID: 15028284 [Abstract] [Full Text] [Related]
8. A 5-bp deletion in ELOVL4 is associated with two related forms of autosomal dominant macular dystrophy. Zhang K, Kniazeva M, Han M, Li W, Yu Z, Yang Z, Li Y, Metzker ML, Allikmets R, Zack DJ, Kakuk LE, Lagali PS, Wong PW, MacDonald IM, Sieving PA, Figueroa DJ, Austin CP, Gould RJ, Ayyagari R, Petrukhin K. Nat Genet; 2001 Jan 31; 27(1):89-93. PubMed ID: 11138005 [Abstract] [Full Text] [Related]
11. [Comparative study of eukaryotic cell expression of wild-type and Pro370Leu mutation type myocilin gene]. Wang JW, Sun HM, Ji J, Li XR, Zheng JQ. Zhonghua Yi Xue Za Zhi; 2006 Mar 14; 86(10):700-4. PubMed ID: 16681932 [Abstract] [Full Text] [Related]
12. Mutant ELOVL4 that causes autosomal dominant stargardt-3 macular dystrophy is misrouted to rod outer segment disks. Agbaga MP, Tam BM, Wong JS, Yang LL, Anderson RE, Moritz OL. Invest Ophthalmol Vis Sci; 2014 May 15; 55(6):3669-80. PubMed ID: 24833735 [Abstract] [Full Text] [Related]